|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-11-29
|
|
pubmed:abstractText |
Somatostatin (sst) are present in the majority of gastro-entero-pancreatic (GEP) tumours. Effects of somatostatin receptor (sst) analogues are partial and of limited duration. Cell lines derived from GEP express dopaminergic receptors D(2). New chimeric analogues simultaneously recognising sst(2) and sst(5) or sst(2) and D(2) have additive effects in inhibition of GH and prolactin secretion in pituitary adenomas. Our aim was to quantify the expression of sst and D(2) mRNA in human GEP tumours.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Somatostatin,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/somatostatin receptor 2,
http://linkedlifedata.com/resource/pubmed/chemical/somatostatin receptor 3,
http://linkedlifedata.com/resource/pubmed/chemical/somatostatin receptor 5
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0804-4643
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
155
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
849-57
|
|
pubmed:meshHeading |
pubmed-meshheading:17132755-Adult,
pubmed-meshheading:17132755-Female,
pubmed-meshheading:17132755-Gastrointestinal Neoplasms,
pubmed-meshheading:17132755-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:17132755-Growth Hormone-Secreting Pituitary Adenoma,
pubmed-meshheading:17132755-Humans,
pubmed-meshheading:17132755-Ki-67 Antigen,
pubmed-meshheading:17132755-Male,
pubmed-meshheading:17132755-Microcirculation,
pubmed-meshheading:17132755-Middle Aged,
pubmed-meshheading:17132755-Pancreatic Neoplasms,
pubmed-meshheading:17132755-Pituitary Neoplasms,
pubmed-meshheading:17132755-RNA, Messenger,
pubmed-meshheading:17132755-Receptors, Dopamine D2,
pubmed-meshheading:17132755-Receptors, Somatostatin,
pubmed-meshheading:17132755-Tumor Markers, Biological,
pubmed-meshheading:17132755-Vascular Endothelial Growth Factor A
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies.
|
|
pubmed:affiliation |
Service of Gastroentérologie-Pancréatologie, Pôle de Maladies de l'Appareil Digestif, Hôpital Beaujon, Clichy, France.
|
|
pubmed:publicationType |
Journal Article
|
